BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19860827)

  • 1. Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
    Voshol H; Ehrat M; Traenkle J; Bertrand E; van Oostrum J
    FEBS J; 2009 Dec; 276(23):6871-9. PubMed ID: 19860827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative phosphoproteomics--an emerging key technology in signal-transduction research.
    Schreiber TB; Mäusbacher N; Breitkopf SB; Grundner-Culemann K; Daub H
    Proteomics; 2008 Nov; 8(21):4416-32. PubMed ID: 18837465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
    Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
    J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor tyrosine kinase signaling: a view from quantitative proteomics.
    Dengjel J; Kratchmarova I; Blagoev B
    Mol Biosyst; 2009 Oct; 5(10):1112-21. PubMed ID: 19756300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse-phase protein microarrays for tissue-based analysis.
    Speer R; Wulfkuhle JD; Liotta LA; Petricoin EF
    Curr Opin Mol Ther; 2005 Jun; 7(3):240-5. PubMed ID: 15977421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody microarrays as an experimental platform for the analysis of signal transduction networks.
    Korf U; Henjes F; Schmidt C; Tresch A; Mannsperger H; Löbke C; Beissbarth T; Poustka A
    Adv Biochem Eng Biotechnol; 2008; 110():153-75. PubMed ID: 18528667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoproteomic approaches to elucidate cellular signaling networks.
    Schmelzle K; White FM
    Curr Opin Biotechnol; 2006 Aug; 17(4):406-14. PubMed ID: 16806894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling receptor tyrosine kinase activation by using Ab microarrays.
    Nielsen UB; Cardone MH; Sinskey AJ; MacBeath G; Sorger PK
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9330-5. PubMed ID: 12876202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput proteomics using antibody microarrays.
    Wingren C; Borrebaeck CA
    Expert Rev Proteomics; 2004 Oct; 1(3):355-64. PubMed ID: 15966831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein microarray detection strategies: focus on direct detection technologies.
    Espina V; Woodhouse EC; Wulfkuhle J; Asmussen HD; Petricoin EF; Liotta LA
    J Immunol Methods; 2004 Jul; 290(1-2):121-33. PubMed ID: 15261576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody microarrays: promises and problems.
    Kusnezow W; Hoheisel JD
    Biotechniques; 2002 Dec; Suppl():14-23. PubMed ID: 12514925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of protein signaling networks in clinical proteomics.
    Geho DH; Petricoin EF; Liotta LA; Araujo RP
    Cold Spring Harb Symp Quant Biol; 2005; 70():517-24. PubMed ID: 16869790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
    VanMeter A; Signore M; Pierobon M; Espina V; Liotta LA; Petricoin EF
    Expert Rev Mol Diagn; 2007 Sep; 7(5):625-33. PubMed ID: 17892368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse phase protein microarrays for theranostics and patient-tailored therapy.
    Espina V; Wulfkuhle J; Calvert VS; Liotta LA; Petricoin EF
    Methods Mol Biol; 2008; 441():113-28. PubMed ID: 18370315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring phosphoproteomic response to targeted kinase inhibitors using reverse-phase protein microarrays.
    Lavezzari G; Lackner MR
    Methods Mol Biol; 2012; 795():203-15. PubMed ID: 21960225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using phosphoproteomics to reveal signalling dynamics in plants.
    de la Fuente van Bentem S; Hirt H
    Trends Plant Sci; 2007 Sep; 12(9):404-11. PubMed ID: 17765599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse-phase protein microarrays.
    Pierobon M; Vanmeter AJ; Moroni N; Galdi F; Petricoin EF
    Methods Mol Biol; 2012; 823():215-35. PubMed ID: 22081348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of signaling pathways in 90 cancer cell lines by protein lysate array.
    Mendes KN; Nicorici D; Cogdell D; Tabus I; Yli-Harja O; Guerra R; Hamilton SR; Zhang W
    J Proteome Res; 2007 Jul; 6(7):2753-67. PubMed ID: 17564428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charging it up: global analysis of protein phosphorylation.
    Ptacek J; Snyder M
    Trends Genet; 2006 Oct; 22(10):545-54. PubMed ID: 16908088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.